Trial Profile
Dolutegravir, Darunavir/Ritonavir and Optimized NRTI Recycling as a Third-line Antiretroviral Regimen in Cambodia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2023
Price :
$35
*
At a glance
- Drugs Abacavir (Primary) ; Darunavir/ritonavir (Primary) ; Dolutegravir (Primary) ; Lamivudine (Primary) ; Tenofovir (Primary) ; Zidovudine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 25 Aug 2021 Planned End Date changed from 3 Oct 2020 to 11 Apr 2022.
- 25 Aug 2021 Planned primary completion date changed from 3 Oct 2020 to 11 Apr 2022.
- 15 Oct 2018 Planned End Date changed from 1 Sep 2020 to 3 Oct 2020.